| pubmed-article:17205569 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17205569 | lifeskim:mentions | umls-concept:C0025663 | lld:lifeskim |
| pubmed-article:17205569 | lifeskim:mentions | umls-concept:C0184511 | lld:lifeskim |
| pubmed-article:17205569 | lifeskim:mentions | umls-concept:C0597198 | lld:lifeskim |
| pubmed-article:17205569 | lifeskim:mentions | umls-concept:C0079611 | lld:lifeskim |
| pubmed-article:17205569 | lifeskim:mentions | umls-concept:C0016263 | lld:lifeskim |
| pubmed-article:17205569 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:17205569 | pubmed:dateCreated | 2007-6-11 | lld:pubmed |
| pubmed-article:17205569 | pubmed:abstractText | The continuous improvement and evolution of immune cell phenotyping requires periodic upgrading of laboratory methods and technology. Flow cytometry laboratories that are participating in research protocols sponsored by the NIAID are required to perform "switch" studies to validate performance before methods for T-cell subset analysis can be changed. | lld:pubmed |
| pubmed-article:17205569 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205569 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205569 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205569 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205569 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205569 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205569 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205569 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205569 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205569 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205569 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205569 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17205569 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205569 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17205569 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17205569 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17205569 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:17205569 | pubmed:issn | 1552-4949 | lld:pubmed |
| pubmed-article:17205569 | pubmed:author | pubmed-author:MargolickJose... | lld:pubmed |
| pubmed-article:17205569 | pubmed:author | pubmed-author:BorowskiLuann... | lld:pubmed |
| pubmed-article:17205569 | pubmed:author | pubmed-author:JamiesonBeth... | lld:pubmed |
| pubmed-article:17205569 | pubmed:author | pubmed-author:MatudJose LJL | lld:pubmed |
| pubmed-article:17205569 | pubmed:author | pubmed-author:HultinLance... | lld:pubmed |
| pubmed-article:17205569 | pubmed:author | pubmed-author:DennyThomas... | lld:pubmed |
| pubmed-article:17205569 | pubmed:author | pubmed-author:O'GormanMauri... | lld:pubmed |
| pubmed-article:17205569 | pubmed:author | pubmed-author:HultinPatrici... | lld:pubmed |
| pubmed-article:17205569 | pubmed:author | pubmed-author:MenendezFrede... | lld:pubmed |
| pubmed-article:17205569 | pubmed:copyrightInfo | Copyright 2007 Clinical Cytometry Society. | lld:pubmed |
| pubmed-article:17205569 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17205569 | pubmed:volume | 72 | lld:pubmed |
| pubmed-article:17205569 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17205569 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17205569 | pubmed:pagination | 249-55 | lld:pubmed |
| pubmed-article:17205569 | pubmed:dateRevised | 2011-9-26 | lld:pubmed |
| pubmed-article:17205569 | pubmed:meshHeading | pubmed-meshheading:17205569... | lld:pubmed |
| pubmed-article:17205569 | pubmed:meshHeading | pubmed-meshheading:17205569... | lld:pubmed |
| pubmed-article:17205569 | pubmed:meshHeading | pubmed-meshheading:17205569... | lld:pubmed |
| pubmed-article:17205569 | pubmed:meshHeading | pubmed-meshheading:17205569... | lld:pubmed |
| pubmed-article:17205569 | pubmed:meshHeading | pubmed-meshheading:17205569... | lld:pubmed |
| pubmed-article:17205569 | pubmed:meshHeading | pubmed-meshheading:17205569... | lld:pubmed |
| pubmed-article:17205569 | pubmed:meshHeading | pubmed-meshheading:17205569... | lld:pubmed |
| pubmed-article:17205569 | pubmed:meshHeading | pubmed-meshheading:17205569... | lld:pubmed |
| pubmed-article:17205569 | pubmed:meshHeading | pubmed-meshheading:17205569... | lld:pubmed |
| pubmed-article:17205569 | pubmed:meshHeading | pubmed-meshheading:17205569... | lld:pubmed |
| pubmed-article:17205569 | pubmed:meshHeading | pubmed-meshheading:17205569... | lld:pubmed |
| pubmed-article:17205569 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17205569 | pubmed:articleTitle | Assessing immunophenotyping performance: proficiency-validation for adopting improved flow cytometry methods. | lld:pubmed |
| pubmed-article:17205569 | pubmed:affiliation | Department of Medicine, Cellular Immunology and Cytometry, University of California, Los Angeles, California, USA. | lld:pubmed |
| pubmed-article:17205569 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17205569 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:17205569 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| pubmed-article:17205569 | pubmed:publicationType | Validation Studies | lld:pubmed |
